Blog

Mark Lewis: This is the football/oncology crossover I’m here for

Photo from Mark Lewis/X

Jun 28, 2024, 00:56

Mark Lewis: This is the football/oncology crossover I’m here for

Mark Lewis shared a post on X:

“This is the football/oncology crossover I’m here for, ⁦Chiara Cremolini⁩!

I agree KEYNOTE-177 v CheckMate 8HW is fraught with the pitfalls of cross-trial comparison (FWIW, I still favor pembro alone unless I really need a quick response making anti-CTLA4 more worthwhile).”

Source: Mark Lewis/X

Mark Lewis is the Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, the Co-Chair of adolescent and young adult (AYA) oncology in the SWOG cooperative group, and the Vice President of American Multiple Endocrine Neoplasia Support. Dr. Lewis is also a well-known patient advocate and social media influencer.
.

anti-CTLA4 cancer cancer treatment CheckMate-8HW Chiara Cremolini Cross-trial comparison ESMO - European Society for Medical Oncology ESMOGI24 EURo2024 football immunotherapy KEYNOTE-177 Mark Lewis OncoDaily Oncology Pembro

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage